Md Ashraf-Uz-Zaman

Md Ashraf-Uz-Zaman

Baylor College of Medicine

H-index: 6

North America-United States

About Md Ashraf-Uz-Zaman

Md Ashraf-Uz-Zaman, With an exceptional h-index of 6 and a recent h-index of 5 (since 2020), a distinguished researcher at Baylor College of Medicine, specializes in the field of Medicinal Chemistry, Drug Discovery, Pharmaceutical Sciences.

His recent articles reflect a diverse array of research interests and contributions to the field:

Design, Synthesis, X-ray Crystallography, and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease

Discovery, Structure–Activity Relationship and In Vitro Anticancer Activity of Small-Molecule Inhibitors of the Protein–Protein Interactions between AF9/ENL and AF4 or DOT1L

Quinazolinone Compounds Have Potent Antiviral Activity against Zika and Dengue Virus

Identifying the Novel Inhibitors Against the Mycolic Acid Biosynthesis Pathway Target “mtFabH” of Mycobacterium tuberculosis

Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis

Emerging importance of tyrosine kinase inhibitors against cancer: quo vadis to cure?

Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer

Assessing the current state of lung cancer chemoprevention: a comprehensive overview

Md Ashraf-Uz-Zaman Information

University

Position

Post-doctoral Associate Houston TX

Citations(all)

83

Citations(since 2020)

69

Cited By

22

hIndex(all)

6

hIndex(since 2020)

5

i10Index(all)

5

i10Index(since 2020)

4

Email

University Profile Page

Google Scholar

Md Ashraf-Uz-Zaman Skills & Research Interests

Medicinal Chemistry

Drug Discovery

Pharmaceutical Sciences

Top articles of Md Ashraf-Uz-Zaman

Design, Synthesis, X-ray Crystallography, and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease

ACS Infectious Diseases

2024/1/9

Discovery, Structure–Activity Relationship and In Vitro Anticancer Activity of Small-Molecule Inhibitors of the Protein–Protein Interactions between AF9/ENL and AF4 or DOT1L

Cancers

2023/11/3

Quinazolinone Compounds Have Potent Antiviral Activity against Zika and Dengue Virus

Journal of Medicinal Chemistry

2023/7/28

Identifying the Novel Inhibitors Against the Mycolic Acid Biosynthesis Pathway Target “mtFabH” of Mycobacterium tuberculosis

Frontiers in Microbiology

2022/5/6

Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis

ACS chemical neuroscience

2022/1/3

Emerging importance of tyrosine kinase inhibitors against cancer: quo vadis to cure?

2021/10/28

Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer

European journal of medicinal chemistry

2021/1/1

Assessing the current state of lung cancer chemoprevention: a comprehensive overview

2020/5/17

Discovery of novel compound promotes neurogenesis by activation of mTOR signaling

The FASEB Journal

2020/4

Md Ashraf-Uz-Zaman
Md Ashraf-Uz-Zaman

H-Index: 3

Discovery and structure‐activity relationship study of novel series of mono‐amine transporter inhibitors for the treatment of neurodegenerative diseases

The FASEB Journal

2020/4

Md Ashraf-Uz-Zaman
Md Ashraf-Uz-Zaman

H-Index: 3

Constantinos Mikelis
Constantinos Mikelis

H-Index: 21

See List of Professors in Md Ashraf-Uz-Zaman University(Baylor College of Medicine)